与 FLCN、BAP1、SDH 和 MET 基因突变相关的肾癌的患病率和放射学特征

IF 5.6 Q1 ONCOLOGY Radiology. Imaging cancer Pub Date : 2024-03-01 DOI:10.1148/rycan.230063
Charlotte Charbel, Pamela I Causa Andrieu, Mohamed Soliman, Sungmin Woo, Junting Zheng, Marinela Capanu, Ines Nikolovski, Hebert A Vargas, Murad Abusamra, Maria I Carlo
{"title":"与 FLCN、BAP1、SDH 和 MET 基因突变相关的肾癌的患病率和放射学特征","authors":"Charlotte Charbel, Pamela I Causa Andrieu, Mohamed Soliman, Sungmin Woo, Junting Zheng, Marinela Capanu, Ines Nikolovski, Hebert A Vargas, Murad Abusamra, Maria I Carlo","doi":"10.1148/rycan.230063","DOIUrl":null,"url":null,"abstract":"<p><p>Purpose To investigate the prevalence of <i>FLCN, BAP1, SDH</i>, and <i>MET</i> mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these mutations. Secondarily, to determine the prevalence of encountered benign renal lesions. Materials and Methods From 25 220 patients with cancer who prospectively underwent germline analysis with a panel of more than 70 cancer-predisposing genes from 2015 to 2021, patients with <i>FLCN, BAP1, SDH</i>, or <i>MET</i> mutations were retrospectively identified. Clinical records were reviewed for patient age, sex, race/ethnicity, and renal cancer diagnosis. If RCC was present, baseline CT and MRI examinations were independently assessed by two radiologists. Summary statistics were used to summarize continuous and categorical variables by mutation. Results A total of 79 of 25 220 (0.31%) patients had a germline mutation: <i>FLCN</i>, 17 of 25 220 (0.07%); <i>BAP1</i>, 22 of 25 220 (0.09%); <i>SDH</i>, 39 of 25 220 (0.15%); and <i>MET</i>, one of 25 220 (0.004%). Of these 79 patients, 18 (23%) were diagnosed with RCC (<i>FLCN</i>, four of 17 [24%]; <i>BAP1</i>, four of 22 [18%]; <i>SDH</i>, nine of 39 [23%]; <i>MET</i>, one of one [100%]). Most hereditary RCCs demonstrated ill-defined margins, central nonenhancing area (cystic or necrotic), heterogeneous enhancement, and various other CT and MR radiologic features, overlapping with the radiologic appearance of nonhereditary RCCs. The prevalence of other benign solid renal lesions (other than complex cysts) in patients was up to 11%. Conclusion <i>FLCN, BAP1, SDH</i>, and <i>MET</i> mutations were present in less than 1% of this oncologic cohort. Within the study sample size limits, imaging findings for hereditary RCC overlapped with those of nonhereditary RCC, and the prevalence of other associated benign solid renal lesions (other than complex cysts) was up to 11%. <b>Keywords:</b> Familial Renal Cell Carcinoma, Birt-Hogg-Dubé Syndrome, Carcinoma, Renal Cell, Paragangliomas, Urinary, Kidney © RSNA, 2024.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"6 2","pages":"e230063"},"PeriodicalIF":5.6000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988346/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Prevalence and Radiologic Features of Renal Cancers Associated with <i>FLCN, BAP1, SDH</i>, and <i>MET</i> Germline Mutations.\",\"authors\":\"Charlotte Charbel, Pamela I Causa Andrieu, Mohamed Soliman, Sungmin Woo, Junting Zheng, Marinela Capanu, Ines Nikolovski, Hebert A Vargas, Murad Abusamra, Maria I Carlo\",\"doi\":\"10.1148/rycan.230063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Purpose To investigate the prevalence of <i>FLCN, BAP1, SDH</i>, and <i>MET</i> mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these mutations. Secondarily, to determine the prevalence of encountered benign renal lesions. Materials and Methods From 25 220 patients with cancer who prospectively underwent germline analysis with a panel of more than 70 cancer-predisposing genes from 2015 to 2021, patients with <i>FLCN, BAP1, SDH</i>, or <i>MET</i> mutations were retrospectively identified. Clinical records were reviewed for patient age, sex, race/ethnicity, and renal cancer diagnosis. If RCC was present, baseline CT and MRI examinations were independently assessed by two radiologists. Summary statistics were used to summarize continuous and categorical variables by mutation. Results A total of 79 of 25 220 (0.31%) patients had a germline mutation: <i>FLCN</i>, 17 of 25 220 (0.07%); <i>BAP1</i>, 22 of 25 220 (0.09%); <i>SDH</i>, 39 of 25 220 (0.15%); and <i>MET</i>, one of 25 220 (0.004%). Of these 79 patients, 18 (23%) were diagnosed with RCC (<i>FLCN</i>, four of 17 [24%]; <i>BAP1</i>, four of 22 [18%]; <i>SDH</i>, nine of 39 [23%]; <i>MET</i>, one of one [100%]). Most hereditary RCCs demonstrated ill-defined margins, central nonenhancing area (cystic or necrotic), heterogeneous enhancement, and various other CT and MR radiologic features, overlapping with the radiologic appearance of nonhereditary RCCs. The prevalence of other benign solid renal lesions (other than complex cysts) in patients was up to 11%. Conclusion <i>FLCN, BAP1, SDH</i>, and <i>MET</i> mutations were present in less than 1% of this oncologic cohort. Within the study sample size limits, imaging findings for hereditary RCC overlapped with those of nonhereditary RCC, and the prevalence of other associated benign solid renal lesions (other than complex cysts) was up to 11%. <b>Keywords:</b> Familial Renal Cell Carcinoma, Birt-Hogg-Dubé Syndrome, Carcinoma, Renal Cell, Paragangliomas, Urinary, Kidney © RSNA, 2024.</p>\",\"PeriodicalId\":20786,\"journal\":{\"name\":\"Radiology. Imaging cancer\",\"volume\":\"6 2\",\"pages\":\"e230063\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988346/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiology. Imaging cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1148/rycan.230063\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology. Imaging cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1148/rycan.230063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的 调查肿瘤学队列中FLCN、BAP1、SDH和MET突变的发生率,并确定与这些突变相关的肾细胞癌(RCC)的发生率、临床特征和影像学特征。其次,确定所遇到的肾脏良性病变的患病率。材料与方法 从 2015 年至 2021 年期间对 25 220 名癌症患者进行了前瞻性种系分析,分析了 70 多个癌症易感基因,并回顾性地确定了 FLCN、BAP1、SDH 或 MET 基因突变的患者。对患者的年龄、性别、种族/民族和肾癌诊断进行了临床记录审查。如果存在 RCC,则由两名放射科医生独立评估基线 CT 和 MRI 检查结果。采用汇总统计法按突变对连续变量和分类变量进行汇总。结果 25 220 例患者中,共有 79 例(0.31%)发生了种系突变:其中,FLCN,25 220 例中有 17 例(0.07%);BAP1,25 220 例中有 22 例(0.09%);SDH,25 220 例中有 39 例(0.15%);MET,25 220 例中有 1 例(0.004%)。在这 79 例患者中,18 例(23%)被诊断为 RCC(FLCN,17 例中的 4 例 [24%];BAP1,22 例中的 4 例 [18%];SDH,39 例中的 9 例 [23%];MET,1 例中的 1 例 [100%])。大多数遗传性 RCC 表现为边缘不清、中央无强化区(囊性或坏死)、异质强化以及各种其他 CT 和 MR 放射学特征,与非遗传性 RCC 的放射学表现重叠。患者中其他良性肾实体病变(复杂囊肿除外)的发病率高达 11%。结论 在这组肿瘤患者中,FLCN、BAP1、SDH和MET突变的比例不到1%。在研究样本量限制范围内,遗传性RCC的成像结果与非遗传性RCC的成像结果重叠,其他相关良性实体肾病变(复杂囊肿除外)的发病率高达11%。关键词: 家族性肾细胞癌家族性肾细胞癌 Birt-Hogg-Dubé 综合征 癌症 肾细胞 副神经节瘤 泌尿 肾脏 © RSNA, 2024.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations.

Purpose To investigate the prevalence of FLCN, BAP1, SDH, and MET mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these mutations. Secondarily, to determine the prevalence of encountered benign renal lesions. Materials and Methods From 25 220 patients with cancer who prospectively underwent germline analysis with a panel of more than 70 cancer-predisposing genes from 2015 to 2021, patients with FLCN, BAP1, SDH, or MET mutations were retrospectively identified. Clinical records were reviewed for patient age, sex, race/ethnicity, and renal cancer diagnosis. If RCC was present, baseline CT and MRI examinations were independently assessed by two radiologists. Summary statistics were used to summarize continuous and categorical variables by mutation. Results A total of 79 of 25 220 (0.31%) patients had a germline mutation: FLCN, 17 of 25 220 (0.07%); BAP1, 22 of 25 220 (0.09%); SDH, 39 of 25 220 (0.15%); and MET, one of 25 220 (0.004%). Of these 79 patients, 18 (23%) were diagnosed with RCC (FLCN, four of 17 [24%]; BAP1, four of 22 [18%]; SDH, nine of 39 [23%]; MET, one of one [100%]). Most hereditary RCCs demonstrated ill-defined margins, central nonenhancing area (cystic or necrotic), heterogeneous enhancement, and various other CT and MR radiologic features, overlapping with the radiologic appearance of nonhereditary RCCs. The prevalence of other benign solid renal lesions (other than complex cysts) in patients was up to 11%. Conclusion FLCN, BAP1, SDH, and MET mutations were present in less than 1% of this oncologic cohort. Within the study sample size limits, imaging findings for hereditary RCC overlapped with those of nonhereditary RCC, and the prevalence of other associated benign solid renal lesions (other than complex cysts) was up to 11%. Keywords: Familial Renal Cell Carcinoma, Birt-Hogg-Dubé Syndrome, Carcinoma, Renal Cell, Paragangliomas, Urinary, Kidney © RSNA, 2024.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.00
自引率
2.30%
发文量
0
期刊最新文献
Multifrequency MR Elastography for Tumor Stiffness Outperforms Conventional Imaging and Clinical Variables in Determining Lymphovascular Space Invasion in Endometrial Cancer. Assessing the Value of 68Ga-FAPI PET/CT in Gastric Mucinous Adenocarcinoma or Signet Ring Cell Carcinoma. External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans. Mathematical 3D Liver Model for Surgical versus Ablative Therapy Treatment Planning for Colorectal Liver Metastases: Recommendations from the COLLISION and COLDFIRE Trial Expert Panels. A New Acquisition Protocol for Optimized Dynamic Susceptibility Perfusion Imaging of Brain Tumors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1